Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target
Open Access
- 6 April 2004
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (9) , 1691-1696
- https://doi.org/10.1038/sj.bjc.6601772
Abstract
Neuropsychological dysfunction associated with cancer and cancer treatment is a growing concern. Methodological limitations permeate the corpus of research in this area and have limited our understanding of the multifactorial nature of this process. The following review provides a summary of the current state of knowledge and highlights future directions.Keywords
This publication has 42 references indexed in Scilit:
- Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literatureJournal of the International Neuropsychological Society, 2003
- Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of lifeAnnals of Neurology, 2003
- Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progressionNeuro-Oncology, 2003
- The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrenceCancer, 2003
- Altered cognitive function in men treated for prostate cancer with luteinizing hormone‐releasing hormone analogues and cyproterone acetate: a randomized controlled trialBJU International, 2002
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- The Effect of Anti‐Oestrogens on Cytokine Production In VitroScandinavian Journal of Immunology, 1996
- Cognitive deficits in patients with small cell lung cancer before and after chemotherapyLung Cancer, 1995
- Neurological and Psychiatric Adverse Effects of Immunological TherapyCNS Drugs, 1995
- Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenismJournal of Assisted Reproduction and Genetics, 1993